Clinipace set for new wave of CRO M&A activity

Clinipace Worldwide has put in place a $50 million ‘war chest’ in a round of debt and equity financing to capitalize on a pipeline of corporate acquisitions. The company has announced that it plans to use the capital to continue building its therapeutic expertise and to further expand its capacity to deliver services to its clients.